Stockreport

Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update

Gain Therapeutics, Inc.  (GANX) 
PDF BETHESDA, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the [Read more]